BackgroundCheck.run
Search For

Stephen M Burleigh, 35300 N 130Th St UNIT 1250, Seattle, WA 98133

Known as:
Stephen Michael Burleigh
Related to:
Ruth A Norris 82 Sandra R Norris 65

Stephen Burleigh Phones & Addresses

300 N 130Th St UNIT 1250, Seattle, WA 98133   

Shoreline, WA   

Moscow, ID   

Redding, CA   

El Cerrito, CA   

Get Report
Control this profile

Mentions for Stephen M Burleigh

Stephen Burleigh resumes & CV records

Resumes

Stephen Burleigh Photo 17

Senior Associate Scientist

Location:
Seattle, WA
Industry:
Biotechnology
Work:
Shape Therapeutics
Senior Associate Scientist Juno Therapeutics, Inc. Feb 2018 - Mar 2019
Senior Research Associate Juno Therapeutics, Inc. Jun 2016 - Feb 2018
Research Associate- Early Pipeline Gene Editing Seattle Children's Mar 2014 - Jun 2016
Research Scientist I University of Idaho Jan 1, 2012 - Jul 1, 2013
Researcher at Top Lab University of New Mexico Clinical and Translational Science Center (Ctsc) Jun 2011 - Jul 2011
Research Fellow
Education:
University of Idaho 2010 - 2013
Bachelors, Bachelor of Science, Microbiology Shasta College 2008 - 2010
Albany High School 2004 - 2008
Skills:
Pcr, Aseptic Technique, Science, Rna Isolation, Public Speaking, Bacterial Cell Culture, Plasmid Isolation, Flow Cytometry, Mammalian Cell Culture, Crispr Guide Design, Cell Biology, Molecular Cloning, Qpcr, Molecular Biology, High Performance Liquid Chromatography, Research, Hplc, Primary Cell Isolation, Gibson Cloning, Primary Cell Transfections
Interests:
Hiking
Swing Dancing
Cooking
Reading
Stephen Burleigh Photo 18

Stephen Burleigh

Stephen Burleigh Photo 19

Stephen J Burleigh

Publications & IP owners

Us Patents

Hpv-Specific Binding Molecules

US Patent:
2021028, Sep 16, 2021
Filed:
Sep 28, 2018
Appl. No.:
16/652379
Inventors:
- Seattle WA, US
- Cambridge MA, US
Christopher BORGES - Cambridge MA, US
Stephen Michael BURLEIGH - Seattle WA, US
Alexandra CROFT - Seattle WA, US
Stephen Jacob GOLDFLESS - Seattle WA, US
David Jeffrey HUSS - Seattle WA, US
Yue JIANG - Seattle WA, US
Timothy G. JOHNSTONE - Seattle WA, US
David KOPPSTEIN - Seattle WA, US
Hieu NGUYEN - Seattle WA, US
Christopher Heath NYE - Seattle WA, US
Haley PEPER - Seattle WA, US
Blythe D. SATHER - Seattle WA, US
Sonia TIMBERLAKE - Seattle WA, US
Dean Y. TOY - Seattle WA, US
Queenie VONG - Seattle WA, US
Gordon Grant WELSTEAD - Cambridge MA, US
James SISSONS - Seattle WA, US
Assignee:
Juno Therapeutics, Inc. - Seattle WA
Editas Medicine, Inc. - Cambridge MA
International Classification:
C07K 14/725
A61P 35/00
A61P 31/20
A61K 35/17
C12N 9/22
C12N 15/11
C12N 15/90
Abstract:
Provided are binding molecules, such as TCRs or antigen binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind human papilloma virus (HPV) 16, including HPV 16 E6 and HPV 16 E7. Also provided are engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment, such as administration of the binding molecules, engineered cells, or compositions.

Methods Of Producing Cells Expressing A Recombinant Receptor And Related Compositions

US Patent:
2021001, Jan 21, 2021
Filed:
Apr 3, 2019
Appl. No.:
17/044221
Inventors:
- Seattle WA, US
- Cambridge MA, US
Stephen Michael BURLEIGH - Seattle WA, US
Christopher Heath NYE - Seattle WA, US
Queenie VONG - Seattle WA, US
Gordon Grant WELSTEAD - Cambridge MA, US
Assignee:
Juno Therapeutics, Inc. - Seattle WA
Editas Medicine, lnc. - Cambridge MA
International Classification:
C07K 14/725
C12N 15/90
A61K 35/17
C12N 5/0783
C07K 14/705
C07K 16/28
A61P 35/00
Abstract:
Provided are methods for engineering immune cells, cell compositions containing engineered immune cells, kits and articles of manufacture for targeting nucleic acid sequence encoding a recombinant receptor to a particular genomic locus and/or for modulating expression of the gene at the genomic locus, and applications thereof in connection with cancer immunotherapy comprising adoptive transfer of engineered T cells. These may involve genetic disruption of at least one site within a TRAC gene and/or a TRBC gene and integration of the transgene encoding for the recombinant receptor at or near one of the at least one target site.

Possible Relatives

Cynthia H Burleigh  Dan D Burleigh  Dennis J Burleigh  Darrell W Burleigh  Douglas R Burleigh  Eric Burleigh  Frank Burleigh  Stephen H Last  Stephen V Johnson  Stephen Stamps 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.